title: Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells.
authors.affiliation: Departments of Medicine and Chemical and Systems Biology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: L X T
authors.initials: LX
authors.lastname: Nguyen
authors.affiliation: Departments of Medicine and Chemical and Systems Biology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Sesay
authors.affiliation: Departments of Medicine and Chemical and Systems Biology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: B S
authors.initials: BS
authors.lastname: Mitchell
mesh_terms: D049109:Cell Proliferation / Q000187:drug effects; D006801:Humans; D007527:Isoenzymes; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011687:Purines / Q000494:pharmacology*; D052999:Quinazolinones / Q000494:pharmacology*; D012335:RNA, Ribosomal / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
chemical_list: D007527:Isoenzymes; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D011687:Purines; D052999:Quinazolinones; D012335:RNA, Ribosomal; C552946:idelalisib